SEC v. Jeremy Jordan-Jones, No. LR-26309, Southern District of New York (May 22, 2025) — Press Release
raw: Jeremy Jordan-Jones
Jeremy Jordan-Jones, No. 1:25-cv-04297 (S.D.N.Y. May 22, 2025)
SEC charged Amalgam Capital Ventures CEO Jeremy Jordan-Jones with offering fraud for misrepresenting technology and finances to secure a $500,000 investment.
Jeremy Jordan-Jones is charged with violating the Securities Act of 1933 and the Securities Exchange Act of 1934 to secure $500,000 in venture capital. He allegedly misrepresented Amalgam's blockchain platform readiness and financial health, while diverting $111,000 of investor funds toward personal expenses. The SEC is seeking permanent injunctions, disgorgement, civil penalties, and an officer-and-director bar.
The SEC charged Jeremy Jordan-Jones, CEO of Amalgam Capital Ventures LLC, with offering fraud to secure a $500,000 investment from a venture capital firm. Between November 2021 and February 2022, Jordan-Jones allegedly used a falsified product deck to claim Amalgam had a nearly complete blockchain-based payment platform. In reality, the company lacked technical capabilities, had no revenue-generating contracts, and maintained a negative bank balance. Upon receiving the investment, Jordan-Jones failed to build the promised infrastructure and instead used at least $111,000 for personal expenses. The SEC is pursuing civil charges for violations of the Securities Act and Exchange Act, seeking disgorgement and an officer-and-director bar. Additionally, the U.S. Attorney’s Office has filed parallel criminal charges against Jordan-Jones.
Exhibits & Attached Documents (1)
Extracted insights
- $500K $500,000 $100K–$1M
- $350K $350,000 $100K–$1M
- $111K $111,000 $100K–$1M
- agency Securities and Exchange Commission
- person that would generate revenues
- company the ceo of amalgam capital ventures llc
- agency the sec’s ongoing investigation
- Securities And Exchange Commission Charges Founder And Ceo Of Start-Up Technology Company With Offering Fraud
- Securities And Exchange Commission Charged Jeremy Jordan-Jones The Ceo Of Amalgam Capital Ventures Llc
- Jeremy Jordan-Jones Making Material Misrepresentations To Convince a Venture Capital Firm To Invest $500,000 With Amalgam
- Jordan-Jones Solicited The Venture Capital Firm By Making Material Misrepresentations In a Product Deck And Due Diligence Report
- Jordan-Jones Misrepresented The Company’S Financial Condition And The Existence Of Certain Professional Partnerships With Other Organizations That Would Generate Revenue For Amalgam
- Amalgam Did Not Possess The Necessary Technical Capabilities Or Infrastructure To Launch The Platform
- Amalgam Had Not Entered Any Contracts That Would Generate Revenues
- Jordan-Jones Failed To Acquire The Purportedly Necessary Infrastructure And Instead Used The Funds For Other Purposes
- Jordan-Jones Used The Funds To Pay At Least $111,000 In Personal Expenses
- The Complaint Charges Jordan-Jones With Violating Section 17(a) Of The Securities Act Of 1933 And Section 10(B) Of The Securities Exchange Act Of 1934 And Rule 10B-5 Thereunder
- The Sec Seeks Permanent Injunctions Disgorgement Plus Prejudgment Interest, a Civil Penalty, And An Officer-And-Director Bar
- The U.S Attorney’S Office For The Southern District Of New York Filed Criminal Charges Against Jordan-Jones
- The Sec’S Ongoing Investigation Is Being Conducted By Mao Yu Lin, Elizabeth Butler, And James Flynn, Under The Supervision Of Sandeep Satwalekar And Thomas P. Smith, Jr., All Of The New York Regional Office
- The Litigation Will Be Led By Travis Hill And Supervised By Jack Kaufman, Also Of The New York Regional Office
U.S. SECURITIES AND EXCHANGE COMMISSION Litigation Release No. 26309 / May 22, 2025 Securities and Exchange Commission v. Jeremy Jordan-Jones, No. 1:25-cv-04297 (S.D.N.Y. filed May 21, 2025) SEC Charges Founder and CEO of Start-Up Technology Company with Offering Fraud On May 21, 2025, the Securities and Exchange Commission charged Jeremy Jordan-Jones, the CEO of Amalgam Capital Ventures LLC, a start-up technology company purportedly based in New York, with making material misrepresentations to convince a venture capital firm to invest $500,000 with Amalgam. According to the complaint, between November 2021 and February 2022, Jordan-Jones solicited the venture capital firm by making material misrepresentations in a product deck and due diligence report, including that Amalgam had developed a blockchain-based point-of-sale payment and processing platform that would be ready to launch commercially after Amalgam acquired approximately $350,000 for infrastructure purposes. According to the complaint, Jordan-Jones also misrepresented the company’s financial condition, as well as the existence of certain professional partnerships with other organizations that would generate revenue for Amalgam. However, as alleged in the complaint, in reality, Amalgam did not possess the necessary technical capabilities or infrastructure to launch the platform, Amalgam had not entered any contracts that would generate revenues, and Amalgam’s bank account had a negative balance. The complaint further alleges, upon receiving the investor’s funds, Jordan-Jones failed to acquire the purportedly necessary infrastructure, and instead used the funds for other purposes, including to pay at least $111,000 in personal expenses. The complaint, filed in the U.S. District Court for the Southern District of New York, charges Jordan-Jones with violating Section 17(a) of the Securities Act of 1933 and Section 10(b) of the Securities Exchange Act of 1934 and Rule 10b-5 thereunder. The SEC seeks permanent injunctions, disgorgement plus prejudgment interest, a civil penalty, and an officer-and-director bar. In a parallel action, the U.S Attorney’s Office for the Southern District of New York filed criminal charges against Jordan-Jones. The SEC’s ongoing investigation is being conducted by Mao Yu Lin, Elizabeth Butler, and James Flynn, under the supervision of Sandeep Satwalekar and Thomas P. Smith, Jr., all of the New York Regional Office. The litigation will be led by Travis Hill and supervised by Jack Kaufman, also of the New York Regional Office.
U.S. SECURITIES AND EXCHANGE COMMISSION Litigation Release No. 26309 / May 22, 2025 Securities and Exchange Commission v. Jeremy Jordan-Jones, No. 1:25-cv-04297 (S.D.N.Y. filed May 21, 2025) SEC Charges Founder and CEO of Start-Up Technology Company with Offering Fraud On May 21, 2025, the Securities and Exchange Commission charged Jeremy Jordan-Jones, the CEO of Amalgam Capital Ventures LLC, a start-up technology company purportedly based in New York, with making material misrepresentations to convince a venture capital firm to invest $500,000 with Amalgam. According to the complaint, between November 2021 and February 2022, Jordan-Jones solicited the venture capital firm by making material misrepresentations in a product deck and due diligence report, including that Amalgam had developed a blockchain-based point-of-sale payment and processing platform that would be ready to launch commercially after Amalgam acquired approximately $350,000 for infrastructure purposes. According to the complaint, Jordan-Jones also misrepresented the company’s financial condition, as well as the existence of certain professional partnerships with other organizations that would generate revenue for Amalgam. However, as alleged in the complaint, in reality, Amalgam did not possess the necessary technical capabilities or infrastructure to launch the platform, Amalgam had not entered any contracts that would generate revenues, and Amalgam’s bank account had a negative balance. The complaint further alleges, upon receiving the investor’s funds, Jordan-Jones failed to acquire the purportedly necessary infrastructure, and instead used the funds for other purposes, including to pay at least $111,000 in personal expenses. The complaint, filed in the U.S. District Court for the Southern District of New York, charges Jordan-Jones with violating Section 17(a) of the Securities Act of 1933 and Section 10(b) of the Securities Exchange Act of 1934 and Rule 10b-5 thereunder. The SEC seeks permanent injunctions, disgorgement plus prejudgment interest, a civil penalty, and an officer-and-director bar. In a parallel action, the U.S Attorney’s Office for the Southern District of New York filed criminal charges against Jordan-Jones. The SEC’s ongoing investigation is being conducted by Mao Yu Lin, Elizabeth Butler, and James Flynn, under the supervision of Sandeep Satwalekar and Thomas P. Smith, Jr., all of the New York Regional Office. The litigation will be led by Travis Hill and supervised by Jack Kaufman, also of the New York Regional Office.